Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration. Ozdemir S, Finkelstein E, Lee JJ, Too IHK, et al. PLoS One 2022;17:e0272301.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ozdemir S, Finkelstein E, Lee JJ, Too IHK, et al. Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration. PLoS One 2022;17:e0272301.
PMID: 35951503